Kevin Keenahan

Kevin Keenahan is the SVP, Business Development, Net Health, and previously co-founder and CEO of Tissue Analytics, Inc., acquired by Net Health in 2020. After completing his BS in Biomedical Engineering at Johns Hopkins University, Kevin joined the Center for Bioengineering Innovation and Design at Johns Hopkins University for his MSE in Bioengineering Innovation and Design.

He went on to cofound Tissue Analytics, Inc. in 2014 and has been recognized as a speaker at several leading industry conferences, including the GSV Pioneer Summit, CES, and the Conference of the European Wound Management Association. Tissue Analytics is a best-in-class wound imaging and documentation solution that uses computer vision to automatically measure and document wound healing.

Below is an excerpt from Kevin Keenahan’s interview with Medium in 2022.

Thank you so much for joining us in this interview series! Before we dig in, our readers would like to get to know you a bit more. Can you tell us a bit about your “backstory”? What led you to this particular career path?

Absolutely! For as long as I can remember, I’ve been interested in how technology and medicine intersect, which made choosing Biomedical Engineering as my undergrad field of study at Johns Hopkins an easy one. And while I learned an immense amount of impactful knowledge while at Johns Hopkins, one of the most important events of my time there was meeting Josh Budman — who, spoiler, would eventually go on to be my co-founder at Tissue Analytics.

After finishing our undergrad, Josh and I stayed friends and both did our Master’s at the Center for Bioengineering Innovation & Design (CBID). CBID is truly an amazing program that gives young engineers the chance to rotate through real-world clinical environments shadowing some of the top doctors and thought leaders in the country.